Cargando…
Etripamil: Self-management of supraventricular tachycardia is not far away?
Autores principales: | Faisaluddin, Mohammed, Ashish, Kumar, Hajra, Adrija, Mondal, Samhati, Bandyopadhyay, Dhrubajyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321861/ https://www.ncbi.nlm.nih.gov/pubmed/30627628 http://dx.doi.org/10.1016/j.ijcha.2018.12.007 |
Ejemplares similares
-
Amyotrophic lateral sclerosis: promising therapeutic outcome–not far away?
por: Hajra, Adrija, et al.
Publicado: (2016) -
Prognostic value of global longitudinal strain in heart failure subjects: A recent prototype
por: Ashish, Kumar, et al.
Publicado: (2018) -
Novel imaging modalities to predict the development of atrial fibrillation post stroke
por: Faisaluddin, Mohammed, et al.
Publicado: (2018) -
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)
por: Stambler, Bruce S., et al.
Publicado: (2022) -
Transcatheter aortic valve replacement: A potential option for aortic insufficiency management in patients with left ventricular assist device
por: Mondal, Samhati, et al.
Publicado: (2019)